Health Trials

Spirometry ,diaphragmatic Ultrasound and Skeletal Muscle Mass in Patients with Chronic Obstructive Pulmonary Disease

ConditionsCOPDUltrasound Therapy; Complications
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age41-70
SponsorAssiut University

About this trial

* The primary objective is to evaluate the use of diaphragmatic function and skeletal muscle mass by ultrasound as a tool to establish the diagnosis of COPD and assess the severity of the disease. * The secondary objective is to compare diaphragmatic function, Skeletal muscle mass, and spirometry results in patients with COPD.

Eligibility criteria

Qualifiers

This group include healthy volunteers who aged ≥ 40 years .

This include stable COPD Patients who will be diagnosed by GOLD 2024 and last excerbation ≥ 6weeks .

Disqualifiers

Patients with disorders that may affect diaphragmatic function as

Musculoskeletal / neurological disorders

diaphragmatic eventration \ hiatus hernia

morbid obesity

Trial design

Treatments tested in this trial

  • ultrasound, spirometry

Treatment groups

64 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Assiut University

Lead sponsor

Source ClinicalTrials.gov